Close Menu

depression

Researchers from Assurex Health and the Mayo Clinic have jointly published data in Pharmacogenetics and Genomics showing that when doctors used the GeneSight pharmacogenomic test to personalize depression treatment for patients they experienced a greater decrease in depr

Ridge Diagnostics this week announced the launch of its MDDScore product, a proteomic test for aiding diagnosis of major depressive disorder.

Roughly one year after securing €5 million ($6.5 million) in venture capital funding, Spanish oligonucleotide drug developer nLife Therapeutics has set its sights on initiating non-human primate testing of its core intranasal delivery technology, which it hopes will spur licensin

SAN FRANCISCO (GenomeWeb News) – Researchers based in the Netherlands and elsewhere are relying on whole-exome sequencing in an isolated population in that country to help track down rare variants associated with complex diseases.

This article has been updated to include information about a competing product in the market.

A group of research centers spanning five continents is in the middle of a clinical trial intended to identify genetic and other markers that can predict response to three antidepressants.

NEW YORK (GenomeWeb News) – A new center in Ontario, Canada focused on pharmacogenetic applications for addiction and mental health has been established with a C$19 million (US$19.1 million) investment.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – San Diego-based Ridge Diagnostics today said that it has licensed exclusive rights to Ameritox to its MDDScore, a multiplex biomarker test for major depressive disorder.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – The Massachusetts General Hospital is starting a major study aimed at guiding treatment of patients suffering from treatment-resistant major depressive disorder.

Pages

A tissue sample from the 1960s harbors a near-complete sample of HIV, IFLScience reports.

A new bill would reshape the US National Science Foundation to include a focus on technological development, according to Science.

The Food and Drug Administration's decision to halt a SARS-CoV-2 study has drawn criticism, according to Stat News.

In Genome Biology this week: features affecting gut microbiome and parasite patterns, cellular interactions in lung tumor microenvironment, and more.